We are live on ! Find out more
NDRAW

ENDRA Life Sciences Inc. Warrants
NDRAW

Delisted

NDRAW was delisted on the 12th of May, 2022.

Back to rankings

1 hedge funds and large institutions have $0 invested in ENDRA Life Sciences Inc. Warrants in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 3 → 1 (-2)

100% less capital invested

Capital invested by funds: $6K → $0 (-$6K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$87

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
– -$6K -35,297 Closed
UBS Group
2
UBS Group
Switzerland
– +$87 +745 +123%

NDRAW Hedge Fund Activity: Q3 2020 in Review

1 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences Inc. Warrants (NDRAW) for Q3 2020, worth a combined $0 — down 100% from $6K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NDRAW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $87. The largest seller was Susquehanna International Group, exiting entirely with an estimated $6K sold.

  • 1 institutional investor held ENDRA Life Sciences Inc. Warrants (NDRAW) as of Q3 2020, down from 3 in Q2 2020.
  • Funds reported $0 of ENDRA Life Sciences Inc. Warrants stock for Q3 2020, down 100% quarter-over-quarter.
  • 0 funds opened new ENDRA Life Sciences Inc. Warrants positions in Q3 2020 and 2 closed out, a net change of -2 holders.
  • The largest ENDRA Life Sciences Inc. Warrants buyer in Q3 2020 was UBS Group, an estimated $87 added.
  • The largest ENDRA Life Sciences Inc. Warrants seller in Q3 2020 was Susquehanna International Group, an estimated $6K sold.

Based on aggregated 13F filings for Q3 2020.